HIF1A and cancer: Furthermore, since oncogenic alterations in miRNA levels are often associated with drug resistance [165,166] and chemoresponses [167,168], the cancer-specific deregulation of HIF-1-related hsa-miR-429 induction may have a significant impact on therapeutic efficiency.